|
Sigurdsson, Einar M (2006) Immunotherapy for conformational diseases. Curr Pharm Des 12:2569-85
|
|
Goni, Fernando; Sigurdsson, Einar M (2005) New directions towards safer and effective vaccines for Alzheimer's disease. Curr Opin Mol Ther 7:17-23
|
|
Goni, F; Knudsen, E; Schreiber, F et al. (2005) Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience 133:413-21
|
|
Sigurdsson, Einar M; Knudsen, Elin; Asuni, Ayodeji et al. (2004) An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives. J Neurosci 24:6277-82
|
|
Berasain, Patricia; Carmona, Carlos; Frangione, Blas et al. (2003) Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi. Mol Biochem Parasitol 130:23-9
|
|
Sigurdsson, Einar M; Brown, David R; Alim, Muhammad A et al. (2003) Copper chelation delays the onset of prion disease. J Biol Chem 278:46199-202
|
|
Sigurdsson, Einar M; Brown, David R; Daniels, Maki et al. (2002) Immunization delays the onset of prion disease in mice. Am J Pathol 161:13-7
|
|
Sigurdsson, E M; Scholtzova, H; Mehta, P D et al. (2001) Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am J Pathol 159:439-47
|
|
Aucouturier, P; Geissmann, F; Damotte, D et al. (2001) Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J Clin Invest 108:703-8
|
|
Vidal, R; Calero, M; Revesz, T et al. (2001) Sequence, genomic structure and tissue expression of Human BRI3, a member of the BRI gene family. Gene 266:95-102
|
Showing the most recent 10 out of 65 publications
